Corbin Capital Partners, L.P. Seagen Inc. Transaction History
Corbin Capital Partners, L.P.
- $35.7 Million
- Q2 2024
A detailed history of Corbin Capital Partners, L.P. transactions in Seagen Inc. stock. As of the latest transaction made, Corbin Capital Partners, L.P. holds 50,000 shares of SGEN stock, worth $0. This represents 11.76% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$0% of portfolio
11.76%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding SGEN
# of Institutions
39Shares Held
1.26MCall Options Held
23KPut Options Held
55.2K-
Pictet Asset Management Sa Geneva 73, V8802KShares$00.19% of portfolio
-
Berry Street Capital Management LLP London, X0206KShares$012.86% of portfolio
-
Tekla Capital Management LLC112KShares$00.86% of portfolio
-
Eaton Vance Management Boston, MA51.3KShares$00.01% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC23KShares$02.7% of portfolio
About Seagen Inc.
- Ticker SGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,664,992
- Description
- Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...